“The revised rating reflects limited operating flexibility as management moves into and operationalizes its new patient tower in fiscal [year] 2017, and as SARH adds new costs to its operating base which may take a couple of years to stabilize given the size and scale of the project,” said S&P analyst Aamna Shah.
The outlook is stable.
More articles on healthcare finance:
For-profit hospital stock report: Week of Dec. 5-9
Zirmed named to Built In Chicago 2016 Top 100 Digital Companies list
Moody’s revises Vidant Health’s outlook to stable
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
